Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Conditions
Leukemia
Interventions
BIOLOGICAL

lintuzumab

DRUG

cytarabine

DRUG

etoposide

DRUG

mitoxantrone hydrochloride

Trial Locations (59)

1000

Institut Jules Bordet, Brussels

2020

Algemeen Ziekenhuis Middelheim, Antwerp

10021

Memorial Sloan-Kettering Cancer Center, New York

New York Presbyterian Hospital - Cornell Campus, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

10595

New York Medical College, Valhalla

11030

North Shore University Hospital, Manhasset

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Milton S. Hershey Medical Center, Hershey

18057

University of Rostock, Rostock

19104

University of Pennsylvania Cancer Center, Philadelphia

20010

Washington Cancer Institute, Washington D.C.

21231

Johns Hopkins Oncology Center, Baltimore

27710

Duke Comprehensive Cancer Center, Durham

30322

Emory Clinic, Atlanta

38117

West Clinic, P.C., Memphis

38801

North Mississippi Hematology and Oncology Associates, Ltd., Tupelo

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

44302

Akron General Medical Center, Akron

49007

West Michigan Cancer Center, Kalamazoo

49033

Centre Hospitalier Regional et Universitaire d'Angers, Angers

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Medical College of Wisconsin, Milwaukee

54511

CHRU de Nancy - Hopitaux de Brabois, Vandœuvre-lès-Nancy

60153

Loyola University Medical Center, Maywood

60612

University of Illinois at Chicago, Chicago

63110

Washington University Barnard Cancer Center, St Louis

89106

Nevada Cancer Center, Las Vegas

91010

Beckman Research Institute, City of Hope, Los Angeles

92121

Sidney Kimmel Cancer Center, San Diego

95816

Sutter Cancer Center, Sacramento

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

92613-5600

St. Joseph Hospital - Orange, Orange

71130-3932

Louisiana State University School of Medicine, Shreveport

02111

New England Medical Center Hospital, Boston

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

08901

Cancer Institute of New Jersey, New Brunswick

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

44106-5065

Ireland Cancer Center, Cleveland

37232-2516

Vanderbilt University Medical Center, Nashville

B-3000

U.Z. Gasthuisberg, Leuven

T6G 1Z2

Cross Cancer Institute, Edmonton

R3A 1R9

Health Sciences Centre, Winnipeg

B3H 2Y9

Queen Elizabeth II Health Science Center, Halifax

M5G 2M9

Princess Margaret Hospital, Toronto

D-12200

Universitaetsklinikum Benjamin Franklin, Berlin

D-60590

Klinikum der J.W. Goethe Universitaet, Frankfurt

D-81675

Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich

DOH-4-8149

Westfaelische Wilhelms-Universitaet, Münster

1105 AZ

Academisch Medisch Centrum, Amsterdam

CB2 2QQ

Addenbrooke's NHS Trust, Cambridge

NW3 2QG

Royal Free Hospital, Hampstead, London

LS1 3EX

Leeds Teaching Hospital Trust, Leeds

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Facet Biotech

INDUSTRY